APA (7th ed.) Citation

A, G., RA, D., R, G., PS, N., R, R., HH, C., . . . A, I. (2026). Prognostic Value of Cycle 1 SPECT SUVmean in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA-617. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 67(6), 921. https://doi.org/10.2967/jnumed.125.271593

Chicago Style (17th ed.) Citation

A, Ghodsi, et al. "Prognostic Value of Cycle 1 SPECT SUVmean in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA-617." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 67, no. 6 (2026): 921. https://doi.org/10.2967/jnumed.125.271593.

MLA (9th ed.) Citation

A, Ghodsi, et al. "Prognostic Value of Cycle 1 SPECT SUVmean in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA-617." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 67, no. 6, 2026, p. 921, https://doi.org/10.2967/jnumed.125.271593.